Why is Bafna Pharma. falling/rising?

As of 09-Sep, Bafna Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 104.80, reflecting a rise of 5.85 or 5.91%. The stock opened with a gain of 2.58% today and reached an intraday high of Rs 104.80. Over the past month, the stock has shown a significant return of 25.03%, outperforming the benchmark Sensex, which only gained 1.56%. Despite a decline in delivery volume by 39.83% compared to the 5-day average, the stock is trading above its moving averages, indicating a strong upward trend. Additionally, the company has demonstrated robust financial performance, with a 944% increase in profits over the past year and a low Debt to EBITDA ratio, which supports its ability to service debt effectively. The increasing participation of institutional investors, who now hold 9.34% of the company, further bolsters confidence in its fundamentals.
In the broader market context, while the BSE500 index has seen negative returns of -2.87% over the last year, Bafna Pharmaceuticals has managed to generate a remarkable return of 34.81%, showcasing its resilience against market trends. This strong performance relative to the benchmark highlights the stock's appeal to investors, particularly in light of its fair valuation compared to peers and the positive sentiment from institutional investors. Overall, the combination of strong financial results, institutional interest, and market-beating performance contributes to the stock's upward movement.